Therapeutic target ID’d for deadly childhood muscle cancer
August 14, 2008
Curbing the activity of a substance called “platelet-derived growth factor receptor A” dramatically reduced aggressiveness of an often-untreatable childhood muscle cancer in mice and cells, a new study from The University of Texas Health Science Center at San Antonio and partner institutions shows.